Gideon M. Hirschfield
Epidemiology · 2003–2017
A researcher in the Science corpus: 6 papers; trusts 1 researcher and is trusted by 1 researcher here, as inferred from the citation graph.
Subfields
- Epidemiology — 41 citations into it; #1,787 of 2,148 by trust here, #493 by citations
- Physiology — 16 citations into it
Whom Gideon M. Hirschfield trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts Gideon M. Hirschfield overall
Papers from Gideon M. Hirschfield's perspective
Ordered by how strongly the researchers Gideon M. Hirschfield trusts endorse each paper. Same corpus, a different order for every researcher.
- Dietary intervention impact on gut microbial gene richness (Nature)
- Biochemical response to ursodeoxycholic acid and long‐term prognosis in primary biliary cirrhosis (Hepatology)
- Bile acid receptors as targets for drug development (Nature Reviews Gastroenterology &Hepatology)
- Obesity alters gut microbial ecology. (Proceedings of the National Academy of Sciences of the United States of America)
- Association between C-reactive protein and features of the metabolic syndrome: a population-based study. (Diabetes Care)
- Human colonic microbiota associated with diet, obesity and weight loss (International Journal of Obesity)
- Microbial ecology: Human gut microbes associated with obesity (Nature)
- Gut metagenome in European women with normal, impaired and diabetic glucose control (Nature)
- Reduced diversity of faecal microbiota in Crohn’s disease revealed by a metagenomic approach (Gut)
- Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases (Proceedings of the National Academy of Sciences of the United States of America)
Their papers
- The gut microbiota and host health: a new clinical frontier (2015) — 2,056 citations
- Targeting C-reactive protein for the treatment of cardiovascular disease (2006) — 711 citations
- EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis. (2017) — 1,219 citations
- A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis. (2016) — 957 citations
- C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. (2004) — 3,082 citations
- C-reactive protein: a critical update. (2003) — 4,141 citations